Chen Zhou, Wei Xiaodong, Dong Shi, Han Fangfang, He Ru, Zhou Wence
The First Clinical Medical College, Lanzhou University, Lanzhou, China.
Department of General Surgery, The First Hospital of Lanzhou University, Lanzhou, China.
Front Oncol. 2022 Apr 12;12:850485. doi: 10.3389/fonc.2022.850485. eCollection 2022.
Pancreatic cancer is one of the most common malignant tumors in the digestive system with a poor prognosis. Accordingly, better understanding of the molecular mechanisms and innovative therapies are warranted to improve the prognosis of this patient population. In addition to playing a crucial role in coagulation, platelets reportedly contribute to the growth, invasion and metastasis of various tumors, including pancreatic cancer. This narrative review brings together currently available evidence on the impact of platelets on pancreatic cancer, including the platelet-related molecular mechanisms of cancer promotion, pancreatic cancer fibrosis, immune evasion, drug resistance mechanisms, thrombosis, targeted platelet therapy, combined radiotherapy and chemotherapy treatment, platelet combined with nanotechnology treatment and potential applications of pancreatic cancer organoids. A refined understanding of the role of platelets in pancreatic cancer provides the foothold for identifying new therapeutic targets.
胰腺癌是消化系统最常见的恶性肿瘤之一,预后较差。因此,有必要更好地了解其分子机制并探索创新疗法,以改善该患者群体的预后。据报道,血小板除了在凝血中起关键作用外,还参与包括胰腺癌在内的各种肿瘤的生长、侵袭和转移。本叙述性综述汇集了目前关于血小板对胰腺癌影响的现有证据,包括血小板促进癌症的相关分子机制、胰腺癌纤维化、免疫逃逸、耐药机制、血栓形成、靶向血小板治疗、联合放化疗治疗、血小板联合纳米技术治疗以及胰腺癌类器官的潜在应用。对血小板在胰腺癌中作用的深入理解为确定新的治疗靶点提供了立足点。